Stockreport

Ultragenyx Pharmaceutical Announces FDA Acceptance of UX016 IND [Yahoo! Finance]

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations
PDF drug (IND) application for UX016, an investigational small-molecule prodrug of sialic acid, which is being developed as a substrate replacement therapy for GNE myopathy [Read more]